DCVC
James Hardiman is an experienced individual who currently holds various positions as an investor and board member in several companies including Recursion Pharmaceuticals, NOETIK, Shennon Biotechnologies, Amogy, Lumafield, Gradle Inc., Stealth Robotics Company, Q-CTRL, and Gro Intelligence. With a background in Engineering Physics from the University of California, Berkeley, and a Master of Business Administration (MBA) from The University of Chicago Booth School of Business, James is actively involved in advancing technologies in biotechnology, software development, quantum technology, sustainable energy, and agriculture data platforms.
DCVC
1 followers
DCVC (Data Collective) and its principals have backed brilliant people changing global-scale industries for over twenty years, helping create tens of billions of dollars of wealth for these entrepreneurs while also making the world a markedly better place. DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 35 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford and Berkeley) with significant tenures at top 100 technology companies and research institutions worldwide. DCVC focuses on seed, Series A, and growth stage companies that apply deep compute, big data and IT infrastructure technologies to transform giant industries.